Yongseop Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yongseop Lee has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Jung Ho Kim
Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
18 shared publications - Jun Yong Choi
Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
17 shared publications - Su Jin Jeong
Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea
17 shared publications - Jin Young Ahn
Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea
15 shared publications - Joon-Sup Yeom
Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea
15 shared publications - Nam Su Ku
Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea
14 shared publications
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Korean Medical Science
- Vol. 42
Changes in Sepsis Hospitalizations and Mortality After Junior Physicians’ Walkout in the Republic of Korea: A Nationwide Interrupted Time-Series Study
Lee Y, et al. J Korean Med Sci. 2027 Jan;42:e6. https://doi.org/10.3346/jkms.2027.42.e6
- 1 January 2027
- Published by XMLink in Journal of Korean Medical Science
- Vol. 42
Open AccessChanges in Sepsis Hospitalizations and Mortality After Junior Physicians’ Walkout in the Republic of Korea: A Nationwide Interrupted Time-Series Study
Lee Y, et al. J Korean Med Sci. 2027 Jan;42:e6. https://doi.org/10.3346/jkms.2027.42.e6
- Open Access
- 11 November 2026
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
Chimerism Analysis Through Shallow Whole-Genome Sequencing and Single-Nucleotide Polymorphism Profiling
Sunghwan Lee, M.D., Yu Jin Park, M.D., Ph.D., Saeam Shin, M.D., Ph.D., Eun-Ki Min, M.D., Yongseop Lee, M.D., Mi Ri Park, B.S., Dongju Won, M.D., Deok-Gie Kim, M.D., Ph.D., Myoung Soo Kim, M.D., Ph.D., Dong Jin Joo, M.D., Ph.D., Jong Rak Choi, M.D., Ph.D., Su Jin Jeong, M.D., Ph.D., Jae Geun Lee, M.D., Ph.D., and Seung-Tae Lee, M.D., Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2026.0068
- 11 November 2026
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
Open AccessChimerism Analysis Through Shallow Whole-Genome Sequencing and Single-Nucleotide Polymorphism Profiling
Sunghwan Lee, M.D., Yu Jin Park, M.D., Ph.D., Saeam Shin, M.D., Ph.D., Eun-Ki Min, M.D., Yongseop Lee, M.D., Mi Ri Park, B.S., Dongju Won, M.D., Deok-Gie Kim, M.D., Ph.D., Myoung Soo Kim, M.D., Ph.D., Dong Jin Joo, M.D., Ph.D., Jong Rak Choi, M.D., Ph.D., Su Jin Jeong, M.D., Ph.D., Jae Geun Lee, M.D., Ph.D., and Seung-Tae Lee, M.D., Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2026.0068
- Open Access
- 15 July 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12  (7) , 519
Risk Factors for Mortality in Candida auris Bloodstream Infection: A Multicenter Study in South Korea, 2018–2025
Candida auris (C. auris) is a multidrug-resistant pathogen that spreads clonally in healthcare settings and was designated an urgent threat by the Centers for Disease Control and Prevention in 2019. We conducted a multicenter study to identify mortality risk factors in C. auris bloodstream infection (BSI) in South Korea. In this retrospective cohort study across three tertiary centers, 50 adults with first-episode C. auris BSI were analyzed. Primary and secondary outcomes were 30- and 90-day mortality. 30-day mortality was 24%, and 90-day mortality was 46%. Older age and higher Sequential Organ Failure Assessment score were independently associated with 30-day mortality. Microbiologic clearance within 30 days was protective. For 90-day mortality, older age was the only independent risk factor, and microbiologic clearance within 90 days was also protective. In conclusion, C. auris BSI causes substantial 30-day mortality, underscoring the need for risk-stratified, clearance-focused management.
- 15 July 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12  (7) , 519
Open AccessRisk Factors for Mortality in Candida auris Bloodstream Infection: A Multicenter Study in South Korea, 2018–2025
Candida auris (C. auris) is a multidrug-resistant pathogen that spreads clonally in healthcare settings and was designated an urgent threat by the Centers for Disease Control and Prevention in 2019. We conducted a multicenter study to identify mortality risk factors in C. auris bloodstream infection (BSI) in South Korea. In this retrospective cohort study across three tertiary centers, 50 adults with first-episode C. auris BSI were analyzed. Primary and secondary outcomes were 30- and 90-day mortality. 30-day mortality was 24%, and 90-day mortality was 46%. Older age and higher Sequential Organ Failure Assessment score were independently associated with 30-day mortality. Microbiologic clearance within 30 days was protective. For 90-day mortality, older age was the only independent risk factor, and microbiologic clearance within 90 days was also protective. In conclusion, C. auris BSI causes substantial 30-day mortality, underscoring the need for risk-stratified, clearance-focused management.
- 7 July 2026
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 67  (10) , 107915
Broad-spectrum empirical antibiotic overuse in community-onset bacteremia: prevalence, outcomes, and associated factors
- 7 July 2026
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 67  (10) , 107915
Broad-spectrum empirical antibiotic overuse in community-onset bacteremia: prevalence, outcomes, and associated factors
- Open Access
- 1 April 2026
- Published by Springer Nature in Journal of Health, Population and Nutrition
- Vol. 45  (1)
Physicians’ understanding of antibiotic prescribing in Korean long-term care hospitals: a multicenter cross-sectional study
The implementation of antimicrobial stewardship programs (ASPs) in long-term care hospitals (LTCHs) is warranted to promote the appropriate use of antibiotics and improve patient outcomes. However, no studies have investigated physicians' understanding of antibiotic use and their perceived need for ASPs within these settings in Korea. In this study, we aimed to assess physicians' understanding of antibiotic use and their perceptions of ASPs in LTCHs. In this multicenter cross-sectional study, we surveyed physicians working in LTCHs. The response rate of the survey was 15.8%. The questionnaire included questions regarding the perceptions and practices of antibiotic use, demand for ASPs, and factors necessary for successful ASPs implementation in LTCHs. Male physicians accounted for 79.2% of respondents. 66.0% and 72.6% of respondents held the incorrect belief that antibiotics were effective in treating unexplained fever and elevated levels of unexplained inflammation, respectively. Adherence to clinical guidelines was suboptimal, with only 46.2% and 28.3% reporting that they selected antibiotics and determined the duration of antibiotic use based on clinical guidelines, respectively. Among the five questions on antibiotic prescription appropriateness, the proportion of respondents who always performed bacterial culture tests before antibiotics initiation and adjusted antibiotics based on the susceptibility results was the lowest (16.0% and 11.3%, respectively). Regarding the perceived need for ASPs, 88.6% agreed that interventions are necessary to improve antibiotic use in LTCHs. The respondents most commonly indicated that a reward system for ASPs (85.8%) and guidelines specific to LTCHs (84.9%) were necessary for the successful implementation of ASPs in these settings. This study highlights substantial gaps in physicians' knowledge and adherence to antibiotic prescription guidelines for LTCHs, necessitating tailored ASPs strategies.
- 1 April 2026
- Published by Springer Nature in Journal of Health, Population and Nutrition
- Vol. 45  (1)
Open AccessPhysicians’ understanding of antibiotic prescribing in Korean long-term care hospitals: a multicenter cross-sectional study
The implementation of antimicrobial stewardship programs (ASPs) in long-term care hospitals (LTCHs) is warranted to promote the appropriate use of antibiotics and improve patient outcomes. However, no studies have investigated physicians' understanding of antibiotic use and their perceived need for ASPs within these settings in Korea. In this study, we aimed to assess physicians' understanding of antibiotic use and their perceptions of ASPs in LTCHs. In this multicenter cross-sectional study, we surveyed physicians working in LTCHs. The response rate of the survey was 15.8%. The questionnaire included questions regarding the perceptions and practices of antibiotic use, demand for ASPs, and factors necessary for successful ASPs implementation in LTCHs. Male physicians accounted for 79.2% of respondents. 66.0% and 72.6% of respondents held the incorrect belief that antibiotics were effective in treating unexplained fever and elevated levels of unexplained inflammation, respectively. Adherence to clinical guidelines was suboptimal, with only 46.2% and 28.3% reporting that they selected antibiotics and determined the duration of antibiotic use based on clinical guidelines, respectively. Among the five questions on antibiotic prescription appropriateness, the proportion of respondents who always performed bacterial culture tests before antibiotics initiation and adjusted antibiotics based on the susceptibility results was the lowest (16.0% and 11.3%, respectively). Regarding the perceived need for ASPs, 88.6% agreed that interventions are necessary to improve antibiotic use in LTCHs. The respondents most commonly indicated that a reward system for ASPs (85.8%) and guidelines specific to LTCHs (84.9%) were necessary for the successful implementation of ASPs in these settings. This study highlights substantial gaps in physicians' knowledge and adherence to antibiotic prescription guidelines for LTCHs, necessitating tailored ASPs strategies.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41  (26) , e183
Ceftazidime-Avibactam Effectiveness in Carbapenem-Resistant Enterobacterales Bacteremia: A Retrospective Cohort Study in Korea
Lee Y, et al. J Korean Med Sci. 2026 Jul;41(26):e183. https://doi.org/10.3346/jkms.2026.41.e183
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41  (26) , e183
Open AccessCeftazidime-Avibactam Effectiveness in Carbapenem-Resistant Enterobacterales Bacteremia: A Retrospective Cohort Study in Korea
Lee Y, et al. J Korean Med Sci. 2026 Jul;41(26):e183. https://doi.org/10.3346/jkms.2026.41.e183
- Open Access
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67  (6) , 458-465
Optimizing Antibiotic Use for Urinary Tract Infections: A Qualitative Assessment of Regular Prescribing Practices
Song JE, et al. Yonsei Med J. 2026 Jun;67(6):458-465. https://doi.org/10.3349/ymj.2025.0332
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67  (6) , 458-465
Open AccessOptimizing Antibiotic Use for Urinary Tract Infections: A Qualitative Assessment of Regular Prescribing Practices
Song JE, et al. Yonsei Med J. 2026 Jun;67(6):458-465. https://doi.org/10.3349/ymj.2025.0332
- Open Access
- 1 January 2026
- Published by XMLink in Infection & Chemotherapy
- Vol. 58  (1) , 19-28
Long-Term Effectiveness and Tolerability of Dolutegravir/Lamivudine in Korea: A 3-Year Follow Up Study
Seong JE, et al. Infect Chemother. 2026 Mar;58(1):19-28. https://doi.org/10.3947/ic.2025.0070
- 1 January 2026
- Published by XMLink in Infection & Chemotherapy
- Vol. 58  (1) , 19-28
Open AccessLong-Term Effectiveness and Tolerability of Dolutegravir/Lamivudine in Korea: A 3-Year Follow Up Study
Seong JE, et al. Infect Chemother. 2026 Mar;58(1):19-28. https://doi.org/10.3947/ic.2025.0070
- Open Access
Respiratory Microbiome of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: A Pilot Study from the Republic of Korea
Ventilator-associated pneumonia (VAP) is one of the most common hospital-acquired infections. Several studies have explored the potential role of the lung microbiome as a biomarker for identifying and predicting the prognosis of VAP. However, research on the respiratory microbiome in individuals with VAP caused by carbapenem-resistant Acinetobacter baumannii (CRAB) remains limited. Therefore, we aimed to analyze the respiratory microbiome of patients with CRAB VAP. Respiratory specimens were collected from patients who developed CRAB VAP. Microbiome diversity and composition were analyzed using 16S rRNA gene pyrosequencing. Patients were categorized into two groups based on mortality outcomes: intensive care unit (ICU) mortality or 28-day mortality after ICU discharge. Twenty patients with CRAB VAP were enrolled, including nine in the mortality group. No significant differences were observed in α-diversity indices between the study groups. However, multivariable Firth’s logistic regression revealed a significant association between a relative abundance of the Enterococcus genus ≥ 1% and mortality outcomes (odds ratio: 0.06; 95% confidence interval: 0.00–0.771; p = 0.029). This study characterized the respiratory microbiome of patients with CRAB VAP and highlighted the potential role of microbiome analysis in predicting disease prognosis. Further studies with larger sample sizes are warranted to validate these findings.
Open AccessRespiratory Microbiome of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: A Pilot Study from the Republic of Korea
Ventilator-associated pneumonia (VAP) is one of the most common hospital-acquired infections. Several studies have explored the potential role of the lung microbiome as a biomarker for identifying and predicting the prognosis of VAP. However, research on the respiratory microbiome in individuals with VAP caused by carbapenem-resistant Acinetobacter baumannii (CRAB) remains limited. Therefore, we aimed to analyze the respiratory microbiome of patients with CRAB VAP. Respiratory specimens were collected from patients who developed CRAB VAP. Microbiome diversity and composition were analyzed using 16S rRNA gene pyrosequencing. Patients were categorized into two groups based on mortality outcomes: intensive care unit (ICU) mortality or 28-day mortality after ICU discharge. Twenty patients with CRAB VAP were enrolled, including nine in the mortality group. No significant differences were observed in α-diversity indices between the study groups. However, multivariable Firth’s logistic regression revealed a significant association between a relative abundance of the Enterococcus genus ≥ 1% and mortality outcomes (odds ratio: 0.06; 95% confidence interval: 0.00–0.771; p = 0.029). This study characterized the respiratory microbiome of patients with CRAB VAP and highlighted the potential role of microbiome analysis in predicting disease prognosis. Further studies with larger sample sizes are warranted to validate these findings.
- Open Access
- 26 February 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 58  (3) , 318-324
Predictors of bloodstream infection and its impact on mortality in septic arthritis: A 15-year review
- 26 February 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 58  (3) , 318-324
Open AccessPredictors of bloodstream infection and its impact on mortality in septic arthritis: A 15-year review